An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...

Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that he wants vaccine skeptic Robert F.

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved in the development and progression of Alzheimer’s disease.

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

Speaking with Megyn Kelly in 2022, Kennedy claimed that Fauci in the 1980s aided Burroughs Wellcome, the developer of AZT and ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

Spero Therapeutics ( (SPRO) ) has released its Q3 earnings. Here is a breakdown of the information Spero Therapeutics presented to its ...

The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs 252 crore in the September quarter, aided by robust sales across segments.

Guggenheim's Inaugural Healthcare Innovation Conference November 12, 2024 2:00 PM ETCompany ParticipantsEmma Walmsley - Chief ...

Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...